Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children

Eric L. Simpson, Lawrence F. Eichenfield, Javier Alonso-Llamazares, Zoe D. Draelos, Laura K. Ferris, Seth B. Forman, Melinda Gooderham, Mercedes E. Gonzalez, Adelaide A. Hebert, Leon H. Kircik, Mark Lomaga, Angela Moore, Kim A. Papp, Vimal H. Prajapati, Diane Hanna, Scott Snyder, David Krupa, Patrick Burnett, Erin Almaraz, Robert C. Higham, David H. Chu, David R. Berk

Open source

DOI: 10.1001/jamadermatol.2024.3121
Published: 2024-11-01
Container: JAMA Dermatology
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2024.3121,
  title = {Roflumilast Cream, 0.15\%, for Atopic Dermatitis in Adults and Children},
  author = {Eric L. Simpson and Lawrence F. Eichenfield and Javier Alonso-Llamazares and Zoe D. Draelos and Laura K. Ferris and Seth B. Forman and Melinda Gooderham and Mercedes E. Gonzalez and Adelaide A. Hebert and Leon H. Kircik and Mark Lomaga and Angela Moore and Kim A. Papp and Vimal H. Prajapati and Diane Hanna and Scott Snyder and David Krupa and Patrick Burnett and Erin Almaraz and Robert C. Higham and David H. Chu and David R. Berk},
  year = {2024},
  journal = {JAMA Dermatology},
  doi = {10.1001/jamadermatol.2024.3121},
  url = {https://doi.org/10.1001/jamadermatol.2024.3121}
}

RIS

TY  - JOUR
TI  - Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children
AU  - Eric L. Simpson
AU  - Lawrence F. Eichenfield
AU  - Javier Alonso-Llamazares
AU  - Zoe D. Draelos
AU  - Laura K. Ferris
AU  - Seth B. Forman
AU  - Melinda Gooderham
AU  - Mercedes E. Gonzalez
AU  - Adelaide A. Hebert
AU  - Leon H. Kircik
AU  - Mark Lomaga
AU  - Angela Moore
AU  - Kim A. Papp
AU  - Vimal H. Prajapati
AU  - Diane Hanna
AU  - Scott Snyder
AU  - David Krupa
AU  - Patrick Burnett
AU  - Erin Almaraz
AU  - Robert C. Higham
AU  - David H. Chu
AU  - David R. Berk
PY  - 2024
JO  - JAMA Dermatology
DO  - 10.1001/jamadermatol.2024.3121
UR  - https://doi.org/10.1001/jamadermatol.2024.3121
ER  -

APA

Simpson, E. L., Eichenfield, L. F., Alonso-Llamazares, J., Draelos, Z. D., Ferris, L. K., Forman, S. B., Gooderham, M., Gonzalez, M. E., Hebert, A. A., Kircik, L. H., Lomaga, M., Moore, A., Papp, K. A., Prajapati, V. H., Hanna, D., Snyder, S., Krupa, D., Burnett, P., Almaraz, E., Higham, R. C., Chu, D. H., & Berk, D. R. (2024). Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.3121

Source records

crossref · retrieved 2026-09-26T17:54:38.194Z